clinical trial · NCT04181723
Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™)
Rett SyndromeTrofinetidePlacebo
brief summary
To investigate the efficacy of treatment with oral trofinetide versus placebo in females with Rett syndrome
started
Nov 6, 2019
primary completion
Oct 28, 2021
completion
Oct 28, 2021
last updated
Apr 8, 2024
official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol